VRSK
56
16
VIX
55
-5
EQIX
59
2
SE
65
5
SO
55
13
CTSH
46
-3
FLR
48
-4
EBAY
62
12
PWR
54
-3
RCL
64
3
AEP
56
5
ABBV
51
-4
IRM
25
4
ITW
33
2
RHI
40
-3
D
53
5
TGT
54
-3
LNC
28
-2
LYB
34
-2
TRV
42
2
VRSK
56
16
VIX
55
-5
EQIX
59
2
SE
65
5
SO
55
13
CTSH
46
-3
FLR
48
-4
EBAY
62
12
PWR
54
-3
RCL
64
3
AEP
56
5
ABBV
51
-4
IRM
25
4
ITW
33
2
RHI
40
-3
D
53
5
TGT
54
-3
LNC
28
-2
LYB
34
-2
TRV
42
2
Financhill
Back

Invesco FTSE RAFI U.S. Index ETF II Vs. Collegium Pharmaceutical Industry Stock Comparison

Sell
34

PXS.TO
Invesco FTSE RAFI U.S. Index ETF II

Last Price:
$50.36
Seasonality Move:
0.77%
Sell
45

COLL
Collegium Pharmaceutical

Last Price:
$33.33
Seasonality Move:
-1.63%
Sell
34
Invesco FTSE RAFI U.S. Index ETF II (PXS.TO) is a Sell

Is Invesco FTSE RAFI U.S. Index ETF II a Buy, Sell or Hold?

  • The current Invesco FTSE RAFI U.S. Index ETF II [PXS.TO] share price is $50.36. The Score for PXS.TO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • PXS.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Collegium Pharmaceutical (COLL) is a Sell

Is Collegium Pharmaceutical a Buy, Sell or Hold?

  • The current Collegium Pharmaceutical [COLL] share price is $33.34. The Score for COLL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • COLL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PXS.TO Stock Price Chart

What is Invesco FTSE RAFI U.S. Index ETF II's stock price today?

  • The Invesco FTSE RAFI U.S. Index ETF II share price today is $50.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PXS.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

COLL Stock Price Chart

What is Collegium Pharmaceutical's stock price today?

  • The Collegium Pharmaceutical share price today is $33.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing buying pressure, which is a positive indicator for future bullish movement.

PXS.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 40.15 Sell
Chaikin Money Flow: 400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.61 - 52.07) Sell
Bollinger Bands (100): (46.79 - 51.07) Buy

COLL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 66.05 Buy
Chaikin Money Flow: 1007158 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.9 - 30.94) Buy
Bollinger Bands (100): (30.52 - 37.92) Sell

PXS.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.51 Sell
20-day SMA: 51.13 Sell
50-day SMA: 50.74 Sell
200-day SMA: 46.99 Buy
8-day EMA: 50.56 Sell
20-day EMA: 50.86 Sell
50-day EMA: 50.47 Sell
200-day EMA: 47.15 Buy

COLL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.45 Buy
20-day SMA: 29.79 Buy
50-day SMA: 30.91 Buy
200-day SMA: 34.47 Sell
8-day EMA: 30.02 Buy
20-day EMA: 29.94 Buy
50-day EMA: 31.21 Buy
200-day EMA: 32.94 Buy

Invesco FTSE RAFI U.S. Index ETF II Earnings Growth & PXS.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.51 per share.

Invesco FTSE RAFI U.S. Index ETF II Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Collegium Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):